Clinical Research and Statistics
In Clinical Research, Statistics plays a prominent role in regulatory submissions. Statistical analysis of Pharmacovigilance can be achieved by several guidelines mainly ICH guidelines. Adverse Drug Reactions reports can also be considered for the regulatory submission.
- Study Design
- Biostatistics
- Data Collection and Management
- Ethical and Regulatory Considerations
Related Conference of Clinical Research and Statistics
August 06-07, 2024
27th World Congress on Nursing, Pharmacology and Healthcare
Aix-en-Provence, France
August 08-09, 2024
30th International Conference on Advanced Clinical Research and Clinical Trials
London, UK
September 11-12, 2024
9th International Conference on Future Pharma and Innovations
Amsterdam, Netherlands
September 12-13, 2024
25th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
Rome, Italy
September 18-19, 2024
3rd World Congress on Medicinal Chemistry and Computer Aided Drug Design
Amsterdam, Netherlands
October 17-18, 2024
4th International Conference and Expo on Biopharmaceutics and Biologic Drugs
London, UK
October 31-01, 2024
27th International Conference and Exhibition on Pharmaceutical Formulations
Amsterdam, Netherlands
November 25-26, 2024
10th International Conference on Antimicrobials & Antibiotic Resistance
Vancouver, Canada
November 26-27, 2024
3rd World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
November 28-29, 2024
41st International Conference on Drug Discovery and Drug delivery system
Paris, France
November 28-29, 2024
16th International Conference on Biosimilars and Pharma Innovations
Bali, Indonesia
December 12-13, 2024
12th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Rome, Italy
March 13-14, 2025
8th International on Pharmacy and Pharmaceutical Conference
Prague, Czech Republic
April 07-08, 2025
4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems
Vancouver, Canada
June 16-17, 2025
18th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Frankfurt, Germany
June 23-24, 2025
25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Aix-en-Provence, France
Clinical Research and Statistics Conference Speakers
Recommended Sessions
- Adverse Drug Reactions
- Biopharmaceutical Sciences
- Case Report in Clinical Trials
- Clinical Data Base Management
- Clinical Research and Statistics
- Clinical Trials on Various Disorders
- Data Quality Management and Analysis
- Diversity in Industrial Clinical Trials and Clinical Research
- Drug Safety
- Forensic Science and Technology
- Good Pharmacovigilance Practice
- Pharmacovigilance and Risk Management
- Pharmacovigilance Significance & Scope
- Pharmacy Practices and its Challenges
- Pre-Clinical and Clinical Trials
- PV Consulting’s and Business opportunity
- Regulatory Affairs
Related Journals
Are you interested in
- Active Pharmaceutical Ingredients - MedTech-2024 (Switzerland)
- Acupuncture - Naturalproducts 2024 (Italy)
- Adaptive Trial Model - Clinical Trials Congress-2024 (France)
- Advanced Drug Delivery System - BIOSIMILARS-2024 (Indonesia)
- Advancements in drug delivery systems - Pharmaceutica-2025 (Canada)
- Advancements in Drug Discovery - Pharmacology-2024 (France)
- Advancements in Psychology Research Methods - Clinical Research 2024 (UK)
- Advances in Controlled Release Formulations - Pharmaceutica-2025 (Canada)
- Advances in Vaccine Delivery - Drug Delivery-2024 (France)
- Advancing Research for rare diseases - ORPHAN DRUGS 2024 (France)
- Adverse Drug Reactions - Pharmacology 2024 (Netherlands)
- Alternative Medicine and Complementary Medicine - Naturalproducts 2024 (Italy)
- Analyses and Quality Control for Pharmaceuticals - Drug Safety 2024 (France)
- Analytical strategies for pharmaceutical products - MedTech-2024 (Switzerland)
- Analytical Techniques in Bioequivalence Assessment - BABE 2024 (UAE)
- Angina Pectoris - Cardiovascular-2024 (France)
- Antibiotic Prophylaxis - Antibiotics Resistance 2024 (Canada)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics Resistance 2024 (Canada)
- Antibiotic-resistant Bacterial infections - Antibiotics Resistance 2024 (Canada)
- Antibiotics - Antibiotics Resistance 2024 (Canada)
- Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2024 (Canada)
- Antimicrobial Peptides - Antibiotics Resistance 2024 (Canada)
- Antimicrobial Therapy - Antibiotics Resistance 2024 (Canada)
- Applied Microbiology - Biotech-2025 (France)
- Applied pharmacology - Euro Pharmacology 2024 (UK)
- Artificial Intelligence (AI) - Personalizedmedicine-2024 (Switzerland)
- Artificial Intelligence and Machine Learning in Drug Delivery Optimization - Pharmaceutica-2025 (Canada)
- Atrial Fibrillation - Cardiovascular-2024 (France)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - Eurobiosimilars 2025 (France)
- Big data analytics and Pharma - Future Pharma 2024 (Netherlands)
- Bio Chemical Pharmacology - Pharmacology 2024 (Netherlands)
- Bio Molecular Dynamics - Biotech-2025 (France)
- Bio-Pharmaceutics - PHARMACEUTICA 2024 (Italy)
- Bioavailability Enhancement Strategies - BABE 2024 (UAE)
- Bioequivalence and Bioavailability - MedTech-2024 (Switzerland)
- Bioequivalence of Generic Drugs and Biosimilars - BABE 2024 (UAE)
- Bioequivalence of Narrow Therapeutic Index Drugs - BABE 2024 (UAE)
- Bioequivalence Study Designs and Methodologies - BABE 2024 (UAE)
- Bioethics and Regulatory Compliance - Clinical Research 2024 (UK)
- Bioethics and Regulatory Compliance - Clinical-Trials-2024 (Canada)
- Bioinformatics in Drug Discovery - PHARAMACEUTICAL CONF 2024 (France)
- Biological Medicine - BIOSIMILARS-2024 (Indonesia)
- Biological Medicine - Eurobiosimilars 2025 (France)
- Biologics & Biosimilars - PHARMACEUTICA 2024 (Italy)
- Biologics and Biosimilars - Pharmaceutica-2025 (Canada)
- Biomarker Discovery and Drug Development - Clinical Trials Congress-2024 (France)
- Biomarkers - Personalizedmedicine-2024 (Switzerland)
- Biomaterials and Biodegradable Polymers in Drug Delivery - Drug Delivery-2024 (France)
- Biomaterials in Drug Delivery - PHARMACEUTICA 2024 (Italy)
- Biomedical Devices Clinical Research - Clinical Research 2024 (UK)
- Biomedical Toxicology - Euro Pharmacology 2024 (UK)
- Biopharmaceutical Formulation Development - Drug Delivery-2024 (France)
- Biopharmaceutical Informatics - BIOSIMILARS-2024 (Indonesia)
- Biopharmaceutical Informatics - Eurobiosimilars 2025 (France)
- Biopharmaceuticals, Biomolecules, and Therapeutics - Drug Safety 2024 (France)
- Biopharmaceutics and Drug Disposition - Pharmaceutica-2025 (Canada)
- Biosimilars - BABE 2024 (UAE)
- Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Biosimilars - Biotech-2025 (France)
- Biosimilars Approval to Biogenerics in Clinical Practice - Eurobiosimilars 2025 (France)
- Biosimilars Development in Markets - Eurobiosimilars 2025 (France)
- Biosimilars Market and Cost Analysis - Eurobiosimilars 2025 (France)
- Biosimilars Research Pipeline - Eurobiosimilars 2025 (France)
- Biotechnology and Microbiology in Pharmaceuticals - Drug Safety 2024 (France)
- Biotechnology in Pharmacotherapy - Pharmacology-2024 (France)
- Biowaivers - BABE 2024 (UAE)
- Biowaivers and Regulatory Exemptions - BABE 2024 (UAE)
- Cancer Biotechnology - Biotech-2025 (France)
- Cancer Clinical Research - Clinical Trials Congress-2024 (France)
- Cardiac Surgery - Cardiovascular-2024 (France)
- Cardio Vascular Pharmacology - Pharmacology 2024 (Netherlands)
- Cardio-Oncology - Cardiovascular-2024 (France)
- Cardiovascular Medicine - Cardiovascular-2024 (France)
- Cellular Targeting and subcellular Delivery - Drug Safety 2024 (France)
- Challenges and Future Innovations of Traditional Medicine - Naturalproducts 2024 (Italy)
- Challenges in Biosimilars Pharmacovigilance - Eurobiosimilars 2025 (France)
- Challenges in Rare Diseases - ORPHAN DRUGS 2024 (France)
- Chemical and Analytical Strategies for Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Chemical and Analytical Strategies for Biosimilars - Eurobiosimilars 2025 (France)
- Chronic Disease Management and Palliative Care - NURSING PHARMACOLOGY 2024 (France)
- Clinical and Hospital Pharmacy - Future Pharma 2024 (Netherlands)
- Clinical and Medical Case Reports - Clinical Research 2024 (UK)
- Clinical Cases in Cardiology - Cardiovascular-2024 (France)
- Clinical Data Management and Analytics - Clinical-Trials-2024 (Canada)
- Clinical Data Management and Statistics - Clinical Research 2024 (UK)
- Clinical Data Strategy and Analytics - Clinical Trials Congress-2024 (France)
- Clinical Operations & Project Management - Clinical-Trials-2024 (Canada)
- Clinical Pharmacology - Euro Pharmacology 2024 (UK)
- Clinical Pharmacology and Pharmacotherapeutics - Euro Pharmacology 2024 (UK)
- Clinical Pharmacology and Receptor Therapy - Clinical Trials Congress-2024 (France)
- Clinical Pharmacovigilance and Drug Safety - PHARAMACEUTICAL CONF 2024 (France)
- Clinical Pharmacy and Pharmacotherapeutics - Pharmacology 2024 (Netherlands)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2024 (Switzerland)
- Clinical Research & Clinical Trials: Academic Perspective - Clinical-Trials-2024 (Canada)
- Clinical Research Nursing - Clinical Research 2024 (UK)
- Clinical Research Statistics - Pharmacology 2024 (Netherlands)
- Clinical Supply Management - Clinical-Trials-2024 (Canada)
- Clinical Toxicology - Euro Pharmacology 2024 (UK)
- Clinical Trial Auditing - Clinical Trials Congress-2024 (France)
- Clinical Trial Forecasting, Budgeting and Contracting - Clinical-Trials-2024 (Canada)
- Clinical Trial Site Selection and Management - Clinical-Trials-2024 (Canada)
- Clinical Trials - Clinical Trials Congress-2024 (France)
- Clinical Trials - Personalizedmedicine-2024 (Switzerland)
- Clinical Trials & Pharmacovigilance - Clinical Trials Congress-2024 (France)
- Clinical Trials and Clinical Research - PHARMACEUTICA 2024 (Italy)
- Clinical Trials and Drug Evaluation - PHARAMACEUTICAL CONF 2024 (France)
- Clinical trials and Pharmacovigilance - MedTech-2024 (Switzerland)
- Clinical Trials in Developing Countries - Clinical Research 2024 (UK)
- Clinical Trials of Antibiotics - Antibiotics Resistance 2024 (Canada)
- Clinical Trials on Different Diseases - Clinical Research 2024 (UK)
- Clinical Trials on different Diseases - Clinical-Trials-2024 (Canada)
- Computational Chemistry in Drug Design - PHARAMACEUTICAL CONF 2024 (France)
- Computer Assisted Drug Design - Biotech-2025 (France)
- Computer Assisted Drug Design - Biotech-2025 (France)
- Consequences of Brexit on Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Consequences of Brexit on Biosimilars - Eurobiosimilars 2025 (France)
- CRO, Sponsorship & Outsourcing for Clinical Trials - Clinical-Trials-2024 (Canada)
- Crude Drugs and Plant Products - Naturalproducts 2024 (Italy)
- Current Advances in Pharmacology - Euro Pharmacology 2024 (UK)
- Current Agency Expectations for Approval for Biosimilars - Eurobiosimilars 2025 (France)
- Current Challenges in Developing Biosimilars - Eurobiosimilars 2025 (France)
- Current research in antibiotic resistance - Antibiotics Resistance 2024 (Canada)
- Data Analytics - Personalizedmedicine-2024 (Switzerland)
- Decentralized Clinical Trials - Clinical Trials Congress-2024 (France)
- Delivery of Medicine via Inhalation - Drug Safety 2024 (France)
- Design of Clinical Studies and Trials - Clinical Research 2024 (UK)
- Developing Alternatives to Antibiotics - Antibiotics Resistance 2024 (Canada)
- Development and Production of Pharmaceutical Products - Drug Safety 2024 (France)
- Devices / CRT / ICD / Surgery - Cardiovascular-2024 (France)
- Diagnostics & Medical Devices - Biotech-2025 (France)
- Digital Health - Personalizedmedicine-2024 (Switzerland)
- Digital Health and Pharmacology - Pharmacology-2024 (France)
- Digital Marketing in Pharma Industry - Future Pharma 2024 (Netherlands)
- Digital Pharma - BIOSIMILARS-2024 (Indonesia)
- Disease Prevention - Personalizedmedicine-2024 (Switzerland)
- Drug delivery - Drug Devilvery 2024 (UAE)
- Drug Delivery and Development - Eurobiosimilars 2025 (France)
- Drug Delivery and Gene Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery Challenges in Neurological Disorders - Drug Delivery-2024 (France)
- Drug Delivery for Cardiovascular Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery in Cancer Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery in Infectious Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery Strategies for Cancer Therapy - Drug Delivery-2024 (France)
- Drug Delivery Technology - Drug Devilvery 2024 (UAE)
- Drug Delivery Technology - BIOSIMILARS-2024 (Indonesia)
- Drug Delivery Technology and Vaccine Design - Drug Safety 2024 (France)
- Drug Delivery through Blood-Brain Barrier (BBB) - Clinical Trials Congress-2024 (France)
- Drug Delivery Using Peptides and Proteins - Drug Safety 2024 (France)
- Drug Design and development - PHARAMACEUTICAL CONF 2024 (France)
- Drug design and development - Drug Devilvery 2024 (UAE)
- Drug Design and Development - Formulations 2024 (Netherlands)
- Drug Designing - Clinical Trials Congress-2024 (France)
- Drug Discovery - Clinical Trials Congress-2024 (France)
- Drug Discovery and Development - Clinical-Trials-2024 (Canada)
- Drug Discovery and Development - Future Pharma 2024 (Netherlands)
- Drug discovery and NCEs - MedTech-2024 (Switzerland)
- Drug Discovery and Novel Delivery Technologies - Antibiotics Resistance 2024 (Canada)
- Drug Formulation - BIOSIMILARS-2024 (Indonesia)
- Drug Formulation Procedures - Formulations 2024 (Netherlands)
- Drug Metabolism and Toxicology - PHARAMACEUTICAL CONF 2024 (France)
- Drug Product Manufacturing - Formulations 2024 (Netherlands)
- Drug Repurposing and Drug Discovery Strategies - PHARAMACEUTICAL CONF 2024 (France)
- Drug Repurposing and Drug Rediscovery - Pharmacology-2024 (France)
- Drug Repurposing and Drug Rediscovery - Drug Delivery-2024 (France)
- Drug Research and Evaluation - Drug Safety 2024 (France)
- Drug Safety - Drug Safety 2024 (France)
- Drug Safety Testing - Pharmacology 2024 (Netherlands)
- Drug Screening and Discovery - Pharmacology 2024 (Netherlands)
- Drug Synthesis and Formulation - PHARAMACEUTICAL CONF 2024 (France)
- Drug Targeting and Design - PHARMACEUTICA 2024 (Italy)
- Drug Targeting and Design - Pharmaceutica-2025 (Canada)
- Drug Transporters and Bioequivalence - BABE 2024 (UAE)
- Ecopharmacovigilance - Pharmacology 2024 (Netherlands)
- Ecopharmacovigilance - Euro Pharmacology 2024 (UK)
- Electronic Health Records (EHRs) - Personalizedmedicine-2024 (Switzerland)
- Emerging Biosimilars in Therapeutics - Eurobiosimilars 2025 (France)
- Emerging Technologies in Drug Discovery - Drug Delivery-2024 (France)
- Encapsulated Drugs - BIOSIMILARS-2024 (Indonesia)
- Enrollment Planning and Patient Recruitment - Clinical-Trials-2024 (Canada)
- Entrepreneurs Investment Meet - ORPHAN DRUGS 2024 (France)
- Entrepreneurs Investment Meet - Formulations 2024 (Netherlands)
- Environmental Toxicology - Euro Pharmacology 2024 (UK)
- Epidemiology and Public Health - Clinical Research 2024 (UK)
- Factors that affect the quality and efficiency of clinical trials - Clinical Trials Congress-2024 (France)
- Food-Drug Interactions in Bioequivalence - BABE 2024 (UAE)
- Forensic Toxicology - Pharmacology 2024 (Netherlands)
- Forensic Toxicology - Euro Pharmacology 2024 (UK)
- Formulation Factors Influencing Bioavailability - BABE 2024 (UAE)
- Formulation Strategies for Follow-on Biologics - Eurobiosimilars 2025 (France)
- Formulations and NNDS - MedTech-2024 (Switzerland)
- Fundamentals of Bioavailability and Bioequivalence Studies - BABE 2024 (UAE)
- Future of Clinical Trials - Clinical Research 2024 (UK)
- Future of Clinical Trials and Technology Innovations - Clinical-Trials-2024 (Canada)
- Future Perspectives in Drug Discovery and Delivery - Drug Delivery-2024 (France)
- Gaming and Abuse of Orphan Drugs - ORPHAN DRUGS 2024 (France)
- Gaseous Dosage Forms - Formulations 2024 (Netherlands)
- Gene Therapy and RNA-based Therapeutics - Drug Delivery-2024 (France)
- General Considerations in Dosage Forms - Formulations 2024 (Netherlands)
- Genetic Testing - Personalizedmedicine-2024 (Switzerland)
- Genomics - Personalizedmedicine-2024 (Switzerland)
- Genomics and Proteomics of Rare Disease - ORPHAN DRUGS 2024 (France)
- Geriatric Nursing and Age-Related Care - NURSING PHARMACOLOGY 2024 (France)
- Global Health Challenges and Healthcare Equity - NURSING PHARMACOLOGY 2024 (France)
- Global Rare Diseases and Orphan Drug Market - ORPHAN DRUGS 2024 (France)
- Globalization of Biosimilars - Eurobiosimilars 2025 (France)
- Globalization of Clinical Trials - Clinical-Trials-2024 (Canada)
- Green and Community Pharmacy - Future Pharma 2024 (Netherlands)
- Health Equity - Personalizedmedicine-2024 (Switzerland)
- Health Toxicology - Euro Pharmacology 2024 (UK)
- Healthcare Policy and Management - NURSING PHARMACOLOGY 2024 (France)
- Heart Transplant Surgery - Cardiovascular-2024 (France)
- Herbal Medicine - Naturalproducts 2024 (Italy)
- Hereditary Angioedema: Diagnosis, Clinical Implications - Clinical Trials Congress-2024 (France)
- Homeopathic and Ayurvedic Medicines - Naturalproducts 2024 (Italy)
- Hypertension - Cardiovascular-2024 (France)
- Hypertrophic Cardiomyopathy - Cardiovascular-2024 (France)
- Imaging Research - Clinical Trials Congress-2024 (France)
- Immunology & Vaccines - Antibiotics Resistance 2024 (Canada)
- Immunopharmacology - Pharmacology 2024 (Netherlands)
- Immunopharmacology - Euro Pharmacology 2024 (UK)
- Immunopharmacology of Autoimmune Disorders - Pharmacology-2024 (France)
- In Vitro-In Vivo Correlation - BABE 2024 (UAE)
- Industrial Bioproceses for Drug Production and Development - Biotech-2025 (France)
- Industrial Pharmacy and Physical pharmacy - Future Pharma 2024 (Netherlands)
- Infectious Diseases - Antibiotics Resistance 2024 (Canada)
- Innovations in clinical study designs - Clinical-Trials-2024 (Canada)
- Innovations in Clinical Trials - Clinical Research 2024 (UK)
- Innovations in Nursing Technology and Informatics - NURSING PHARMACOLOGY 2024 (France)
- Innovations in Oral Drug Delivery Systems - Drug Delivery-2024 (France)
- Innovations in Pre-clinical Research - Clinical Research 2024 (UK)
- Innovative Clinical Approach in Biosimilars - Eurobiosimilars 2025 (France)
- Integrative Medicine and Holistic Healthcare - NURSING PHARMACOLOGY 2024 (France)
- Intellectual Property Rights - BIOSIMILARS-2024 (Indonesia)
- Intellectual Property Rights - Eurobiosimilars 2025 (France)
- Intellectual property rights and regulatory issues - Drug Safety 2024 (France)
- Interventional Cardiology - Cardiovascular-2024 (France)
- Latest technologies in Biomedical Research - Clinical Research 2024 (UK)
- Legal Issues and BPCI Act - Eurobiosimilars 2025 (France)
- Lifestyle Medicine - Personalizedmedicine-2024 (Switzerland)
- Liquid Dosage Forms - Formulations 2024 (Netherlands)
- Living with a Rare Disease - ORPHAN DRUGS 2024 (France)
- Marine Natural Products - Naturalproducts 2024 (Italy)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics Resistance 2024 (Canada)
- Medical and Clinical Case Reports - Clinical-Trials-2024 (Canada)
- Medical Devices for Drug Delivery - PHARMACEUTICA 2024 (Italy)
- Medical Imaging in Clinical Research - Clinical-Trials-2024 (Canada)
- Medicinal Chemistry - Naturalproducts 2024 (Italy)
- Medicinal Plant Research - Naturalproducts 2024 (Italy)
- Medicinal Plants as Anti-Cancer Drugs - Naturalproducts 2024 (Italy)
- Mental Health and Psychiatric Nursing - NURSING PHARMACOLOGY 2024 (France)
- Micro Organisms in Recent Drug Discovery - Antibiotics Resistance 2024 (Canada)
- Microbial & Environmental Biotechnology - Biotech-2025 (France)
- Microbiology Clinical Research - Clinical Research 2024 (UK)
- Minimally Invasive Heart Surgery - Cardiovascular-2024 (France)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2024 (Canada)
- Modern drug delivery techniques - Drug Safety 2024 (France)
- Molecualr Biotechnology - Biotech-2025 (France)
- Molecular and Clinical Pharmacology - Pharmacology 2024 (Netherlands)
- Molecular and Clinical Pharmacology - Euro Pharmacology 2024 (UK)
- Monoclonal Antibody Biosimilars - Eurobiosimilars 2025 (France)
- Nano medicine and Nanotechnology in Drug Delivery - Pharmaceutica-2025 (Canada)
- Nano particulate Drug Delivery Systems - PHARMACEUTICA 2024 (Italy)
- Nanomedicine and Biomedical Applications - PHARMACEUTICA 2024 (Italy)
- Nanotechnology Applications in Drug Delivery - Drug Delivery-2024 (France)
- Natural Products - Naturalproducts 2024 (Italy)
- Natural Products Chemistry - Naturalproducts 2024 (Italy)
- Natural Products in Drug Development - PHARAMACEUTICAL CONF 2024 (France)
- Neuro Pharmacology - Pharmacology 2024 (Netherlands)
- New Advances in Drug Delivery Systems - Drug Safety 2024 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics Resistance 2024 (Canada)
- New Sources and Approaches to Natural Products - Naturalproducts 2024 (Italy)
- Novel Drug Delivery Systems - Future Pharma 2024 (Netherlands)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2024 (Switzerland)
- Novel Drug Delivery Technologies - Drug Delivery-2024 (France)
- Novel Drug Delivery Technologies - Pharmaceutica-2025 (Canada)
- Novel Drug Dery Systems - Formulations 2024 (Netherlands)
- Nursing Education and Practice - NURSING PHARMACOLOGY 2024 (France)
- Nursing Leadership and Professional Development - NURSING PHARMACOLOGY 2024 (France)
- Nursing Research and Evidence-Based Practice - NURSING PHARMACOLOGY 2024 (France)
- Nutraceuticals and Functional Medicine - Naturalproducts 2024 (Italy)
- Ocular Pharmacology - Pharmacology 2024 (Netherlands)
- Oncology Clinical Research - Clinical Research 2024 (UK)
- Open-Heart Surgery - Cardiovascular-2024 (France)
- Orphan Drug Therapeutics - ORPHAN DRUGS 2024 (France)
- Orphan Drugs Clinical Research - ORPHAN DRUGS 2024 (France)
- Overview on Rare Diseases - ORPHAN DRUGS 2024 (France)
- Patient Concerns for Orphan Drugs - ORPHAN DRUGS 2024 (France)
- Patient Recruiting & Retention - Clinical Research 2024 (UK)
- Patient Safety and Quality Improvement - NURSING PHARMACOLOGY 2024 (France)
- Patient-Cantered Care - Personalizedmedicine-2024 (Switzerland)
- Patient-Centric Clinical Trials - Clinical-Trials-2024 (Canada)
- Pediatric and Geriatric Bioequivalence - BABE 2024 (UAE)
- Peptide and Protein Drug Delivery - Pharmaceutica-2025 (Canada)
- Percutaneous Cardiovascular Interventions - Cardiovascular-2024 (France)
- Personalized Healthcare - Personalizedmedicine-2024 (Switzerland)
- Pharma and Biotech Financial Outlook - Future Pharma 2024 (Netherlands)
- Pharma Market Research - MedTech-2024 (Switzerland)
- Pharmaceutical Analysis - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Analysis - Future Pharma 2024 (Netherlands)
- Pharmaceutical Analysis - Formulations 2024 (Netherlands)
- Pharmaceutical and healthcare Industry - Future Pharma 2024 (Netherlands)
- Pharmaceutical Chemistry - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Chemistry - Future Pharma 2024 (Netherlands)
- Pharmaceutical Chemistry - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Drug Discovery and Nanotechnology - Clinical Trials Congress-2024 (France)
- Pharmaceutical Excipients - Formulations 2024 (Netherlands)
- Pharmaceutical Formulation - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Formulation - Formulations 2024 (Netherlands)
- Pharmaceutical Formulation Technologies - Clinical Trials Congress-2024 (France)
- Pharmaceutical Formulations Market - Formulations 2024 (Netherlands)
- Pharmaceutical Manufacturing - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Manufacturing - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2024 (Switzerland)
- Pharmaceutical Nanotechnology - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Nanotechnology - PHARAMACEUTICAL CONF 2024 (France)
- Pharmaceutical Organic Chemistry - Clinical Trials Congress-2024 (France)
- Pharmaceutical Packaging - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Packaging and Logistics - MedTech-2024 (Switzerland)
- Pharmaceutical Process Validation - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Regulatory Affairs and Intellectual Property Rights - PHARMACEUTICA 2024 (Italy)
- Pharmaceutical Sciences - Clinical-Trials-2024 (Canada)
- Pharmaceutical Sciences - MedTech-2024 (Switzerland)
- Pharmaceutical Technology - Clinical Trials Congress-2024 (France)
- Pharmaceuticals and Drug Delivery Systems Using Nanotechnology - Drug Safety 2024 (France)
- Pharmaceutics & Pharmacotherapeutics - Future Pharma 2024 (Netherlands)
- Pharmacists Role in Patient Safety - Formulations 2024 (Netherlands)
- Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmacogenetics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenetics and Genomics - PHARMACEUTICA 2024 (Italy)
- Pharmacogenetics and Personalized Medicine - Pharmacology-2024 (France)
- Pharmacogenomics - Drug Safety 2024 (France)
- Pharmacogenomics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenomics - BIOSIMILARS-2024 (Indonesia)
- Pharmacogenomics and Personalized Medicine - PHARAMACEUTICAL CONF 2024 (France)
- Pharmacogenomics and Personalized Medicine - BABE 2024 (UAE)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2024 (Switzerland)
- Pharmacokinetic Parameters and Analysis - BABE 2024 (UAE)
- Pharmacokinetics and Pharmacodynamics - Pharmacology-2024 (France)
- Pharmacokinetics and Pharmacodynamics - Pharmaceutica-2025 (Canada)
- Pharmacokinetics and Pharmacodynamics in Drugs - PHARMACEUTICA 2024 (Italy)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics Resistance 2024 (Canada)
- Pharmacological Advances and Drug Development - NURSING PHARMACOLOGY 2024 (France)
- Pharmacological Testing - Euro Pharmacology 2024 (UK)
- Pharmacology - Pharmacology 2024 (Netherlands)
- Pharmacology - Drug Safety 2024 (France)
- Pharmacology - Euro Pharmacology 2024 (UK)
- Pharmacology & Toxicology - Antibiotics Resistance 2024 (Canada)
- Pharmacology and Toxicology - ORPHAN DRUGS 2024 (France)
- Pharmacology and Toxicology - MedTech-2024 (Switzerland)
- Pharmacology of Addiction and Substance Abuse - Pharmacology-2024 (France)
- Pharmacology of Aging and Geriatric Medicine - Pharmacology-2024 (France)
- Pharmacology of Antimicrobial Resistance - Pharmacology-2024 (France)
- Pharmacology of Cancer Immunotherapy - Pharmacology-2024 (France)
- Pharmacology of Cardiovascular Therapeutics - Pharmacology-2024 (France)
- Pharmacology of Neurodegenerative Disorders - Pharmacology-2024 (France)
- Pharmacology of Nutraceuticals and Dietary Supplements - Pharmacology-2024 (France)
- Pharmacology of Pain Management and Analgesia - Pharmacology-2024 (France)
- Pharmacology of Rare Diseases - Pharmacology-2024 (France)
- Pharmacology of Respiratory Diseases: - Pharmacology-2024 (France)
- Pharmacovigilance - Clinical Trials Congress-2024 (France)
- Pharmacovigilance and Drug Safety - Clinical Research 2024 (UK)
- Pharmacovigilance and Drug Safety - Clinical-Trials-2024 (Canada)
- Pharmacovigilance in the Era of Big Data - Pharmacology-2024 (France)
- Pharmacovigilance Significance and Scope - Pharmacology 2024 (Netherlands)
- Pharmacy and Pharmaceutical Technology - Euro Pharmacology 2024 (UK)
- Phytochemistry - Naturalproducts 2024 (Italy)
- Population Health - Personalizedmedicine-2024 (Switzerland)
- Post Marketing Surveillance - Clinical Trials Congress-2024 (France)
- Post-Clinical Trial closed communities - Clinical Trials Congress-2024 (France)
- Pre-clinical and Clinical Trails - Pharmacology 2024 (Netherlands)
- Precision Medicine - Personalizedmedicine-2024 (Switzerland)
- Precision Medicine and Pharmacogenomics - NURSING PHARMACOLOGY 2024 (France)
- Preformulation Research - Drug Safety 2024 (France)
- Public Health and Community Nursing - NURSING PHARMACOLOGY 2024 (France)
- QC & QA: Quality control and Quality assurance - MedTech-2024 (Switzerland)
- Quality by design(QbD) approach - MedTech-2024 (Switzerland)
- Quality Control and Regulatory Considerations in Drug Delivery Systems - Pharmaceutica-2025 (Canada)
- Radiation-based medicines and biotherapy - Drug Safety 2024 (France)
- Rare Diseases and Ultra Rare Diseases - ORPHAN DRUGS 2024 (France)
- Rare Genetic Diseases/Disorder - ORPHAN DRUGS 2024 (France)
- Real-World Evidence in Clinical Trials - Clinical Research 2024 (UK)
- Recent advances in drug delivery - Drug Devilvery 2024 (UAE)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2024 (Netherlands)
- Recent Advances in Pharmacology and Toxicology - Pharmacology 2024 (Netherlands)
- Recent Advances in Pharmacology and Toxicology - Euro Pharmacology 2024 (UK)
- Regenerative Medicine and Tissue Engineering - Drug Delivery-2024 (France)
- Regulatory Affairs - Formulations 2024 (Netherlands)
- Regulatory Affairs and Intellectual Property Rights - Future Pharma 2024 (Netherlands)
- Regulatory Affairs and Quality Assurance in Pharmaceutics - Pharmaceutica-2025 (Canada)
- Regulatory Affairs in Pharmaceutical Industry - PHARAMACEUTICAL CONF 2024 (France)
- Regulatory Authority Compliance - MedTech-2024 (Switzerland)
- Regulatory Considerations in Drug Development - Drug Delivery-2024 (France)
- Regulatory Updates on Biosimilars - Eurobiosimilars 2025 (France)
- Research and development in pharmaceuticals - Drug Safety 2024 (France)
- Research and Trials on Oncology and AIDS - Clinical-Trials-2024 (Canada)
- Revolutionary Changes - ORPHAN DRUGS 2024 (France)
- Safety of drugs and pharmacovigilance - Drug Safety 2024 (France)
- Safety Pharmacology - Pharmacology 2024 (Netherlands)
- Semi-Solid Dosage Forms - Formulations 2024 (Netherlands)
- Site Management Innovation - Clinical Research 2024 (UK)
- Smart Drug Delivery Systems - PHARMACEUTICA 2024 (Italy)
- Smart Drug Dery Systems - Formulations 2024 (Netherlands)
- Smart Polymers for Drug Delivery - Pharmaceutica-2025 (Canada)
- Solid Dosage Forms - Formulations 2024 (Netherlands)
- Stem Cell and Genetic Clinical Research - Clinical Research 2024 (UK)
- Sustainability and Global Health Biotechnology - Biotech-2025 (France)
- Targeted Therapies - Personalizedmedicine-2024 (Switzerland)
- Technologies for Formulation - Drug Safety 2024 (France)
- Technology in Pharma Sciences - MedTech-2024 (Switzerland)
- Telemedicine - Personalizedmedicine-2024 (Switzerland)
- The BBB for drug delivery - Drug Safety 2024 (France)
- The Future of Pharma R&D - Future Pharma 2024 (Netherlands)
- The Next Generation Approach of Antibiotics - Antibiotics Resistance 2024 (Canada)
- Therapeutic Drug Transporters - Drug Safety 2024 (France)
- Toxicological Pharmacovigilance - Euro Pharmacology 2024 (UK)
- Toxicology - Pharmacology 2024 (Netherlands)
- Toxicology - Euro Pharmacology 2024 (UK)
- Translational Research - Personalizedmedicine-2024 (Switzerland)
- Translational Research in Pharmacology and Therapeutics - NURSING PHARMACOLOGY 2024 (France)
- Types of Formulations - Formulations 2024 (Netherlands)
- USFDA Approved Biosimilars - Eurobiosimilars 2025 (France)
- Vaccine Delivery Systems - Pharmaceutica-2025 (Canada)
- Vaccine Drug Delivery Systems - PHARMACEUTICA 2024 (Italy)